Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharmaceuticals Regulatory News (CEL)

  • This share is currently suspended. It was suspended at a price of 13.40
  • There is currently no data for CEL

Share Options

31 Jul 2006 16:47

Celsis International PLC31 July 2006 Celsis International PLC Share Options 31 July 2006: Celsis International plc today announces that under the terms ofthe 2005 Share Performance Plan, Jay LeCoque, Chief Executive and ChristianMadrolle, Finance Director, have respectively been awarded 113,398 and 87,478Share Options at a price of 5p per share on 26 July 2006. These Share Options are subject to the achievement of performance criteria asdetailed in the Share Performance Plan and in the Celsis 2006 Annual Report andAccounts Remuneration Report. Enquiries:Celsis International plc Tel: 01638 600 151Christian Madrolle, Finance Director & Company SecretaryJenny Parsons, Corporate Communications Financial Dynamics Tel: 020 7831 3113David YatesAnna Keeble This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
4th Aug 20058:00 amRNSDirector/PDMR Shareholding
26th Jul 20055:07 pmRNSResult of AGM
26th Jul 20057:00 amRNSAGM Statement
18th Jul 20054:35 pmRNSDividend Declaration
11th Jul 20054:58 pmRNSHolding(s) in Company
30th Jun 200511:42 amRNSAnnual Report and Accounts
28th Jun 20057:01 amRNSRe: Share Capital
10th Jun 20053:38 pmRNSTreasury Stock
6th Jun 20054:59 pmRNSDirector Shareholding
2nd Jun 200511:03 amRNSHolding(s) in Company
31st May 20059:07 amRNSDirector Shareholding
24th May 20057:01 amRNSFinal Results
16th May 20054:08 pmRNSNotice of Results
1st Apr 20057:00 amRNSTrading Statement
1st Mar 20057:01 amRNSBoard Change
18th Feb 20054:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.